Toxicity during induction of pulsed versus continuous prednisolone in children with acute lymphoblastic leukaemia: a multi-centre, open label, randomised, phase 3 trial from India (2016–2022)
The Lancet Regional Health - Southeast Asia · 2026-07 · 50 · 100788
DOI: 10.1016/j.lansea.2026.100788 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Lancet Regional Health - Southeast Asia, 2026-07. Verfasst von Parag Das und 17 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Research Unit, Tata Translational Cancer Research Centre, Tata Medical Center, Kolkata, West Bengal, 700160, India. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Department of Biotechnology, Ministry of Science and Technology, India, Wellcome Trust DBT India Alliance.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinical Research Unit, Tata Translational Cancer Research Centre, Tata Medical Center, Kolkata, West Bengal, 700160, India.
- Department of Pediatric Oncology, Tata Memorial Centre, Tata Memorial Hospital, Mumbai, Maharashtra 400012, India.
- Homi Bhabha National Institute, Mumbai, Maharashtra, 400 094, India.
- Pediatric Hematology-Oncology Unit, Department of Pediatrics, Advanced Pediatrics Center, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012, India.
- Department of Medical Oncology, BR Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, 110029, India.
- Department of Medical Oncology, Cancer Institute (WIA), Adyar, Chennai, Tamil Nadu 600020, India.
Förderung
- Wellcome Trust
- Department of Biotechnology, Ministry of Science and Technology, India
- Wellcome Trust DBT India Alliance
- Tata Consultancy Services Limited
- Indian Council of Medical Research
Zitieren
APA
Das, P., Das, N., Narula, G., Trehan, A., Bakhshi, S., Radhakrishnan, V., Seth, R., Tembhare, P., Singh Sachdeva, M. U., Chopra, A., Sundersingh, S., Das, S., Gogoi, M. P., Parihar, M., Bhattacharya, R., Banavali, S., Saha, V., & Krishnan, S. (2026). Toxicity during induction of pulsed versus continuous prednisolone in children with acute lymphoblastic leukaemia: a multi-centre, open label, randomised, phase 3 trial from India (2016–2022). The Lancet Regional Health - Southeast Asia, 50, 100788. https://doi.org/10.1016/j.lansea.2026.100788
Vancouver
Das P, Das N, Narula G, Trehan A, Bakhshi S, Radhakrishnan V, et al. Toxicity during induction of pulsed versus continuous prednisolone in children with acute lymphoblastic leukaemia: a multi-centre, open label, randomised, phase 3 trial from India (2016–2022). The Lancet Regional Health - Southeast Asia. 2026;50:100788. doi:10.1016/j.lansea.2026.100788
BibTeX
@article{Das2026,
author = {Das, Parag and Das, Nandana and Narula, Gaurav and Trehan, Amita and Bakhshi, Sameer and Radhakrishnan, Venkatraman and Seth, Rachna and Tembhare, Prashant and Singh Sachdeva, Man Updesh and Chopra, Anita and Sundersingh, Shirley and Das, Soumyadeep and Gogoi, Manash Pratim and Parihar, Mayur and Bhattacharya, Rahul and Banavali, Shripad and Saha, Vaskar and Krishnan, Shekhar},
title = {Toxicity during induction of pulsed versus continuous prednisolone in children with acute lymphoblastic leukaemia: a multi-centre, open label, randomised, phase 3 trial from India (2016–2022)},
journal = {The Lancet Regional Health - Southeast Asia},
year = {2026},
volume = {50},
pages = {100788},
doi = {10.1016/j.lansea.2026.100788}
}
EUVIMED